Maternal and fetal outcome of pregnancy in Swiss mice infected with Plasmodium berghei ANKAGFP

Reprod Toxicol. 2019 Oct:89:107-114. doi: 10.1016/j.reprotox.2019.07.011. Epub 2019 Jul 13.

Abstract

Malaria in pregnant women is associated with risk of maternal and perinatal morbidity and mortality, and there are few antimalarial drugs considered safe to treat them, so it is necessary to develop safer antimalarial medicines. The goal of this study was to develop an animal model for human malaria during pregnancy by characterizing the maternal and fetal outcomes in malaria infected Swiss mice. For that, in the present study, we evaluated the outcome of pregnancy in Swiss mice infected with Plasmodium berghei ANKAGFP. We observed a reduction of fetal body weight and signs of skeletal ossification retardation in the offspring of mice infected on GD 12. The group of mice infected with malaria presented premature deliveries and histopathology changes consistent with placental malaria. Our study suggests that Swiss Webster mice infected with P. berghei ANKAGFP on GD 12 might be a valuable model to investigate the safety and the efficacy of new antimalarial drugs indicated to pregnant women.

Keywords: Intrauterine growth restriction; Malaria model; Placental histopathology; Skeletal teratology; Swiss mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Antimalarials / administration & dosage
  • Antimalarials / therapeutic use*
  • Disease Models, Animal
  • Female
  • Fetal Development / drug effects*
  • Fetal Growth Retardation / parasitology
  • Fetal Growth Retardation / prevention & control*
  • Gestational Age
  • Malaria / drug therapy*
  • Malaria / parasitology
  • Plasmodium berghei / drug effects*
  • Plasmodium berghei / growth & development
  • Pregnancy
  • Pregnancy Complications, Parasitic / drug therapy*
  • Pregnancy Complications, Parasitic / parasitology
  • Pregnancy Outcome

Substances

  • Antimalarials